These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19581416)

  • 1. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1.
    Cardellini M; Menghini R; Martelli E; Casagrande V; Marino A; Rizza S; Porzio O; Mauriello A; Solini A; Ippoliti A; Lauro R; Folli F; Federici M
    Diabetes; 2009 Oct; 58(10):2396-401. PubMed ID: 19581416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice.
    Jiang JX; Chen X; Fukada H; Serizawa N; Devaraj S; Török NJ
    Hepatology; 2013 Oct; 58(4):1339-48. PubMed ID: 23703665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans.
    Monroy A; Kamath S; Chavez AO; Centonze VE; Veerasamy M; Barrentine A; Wewer JJ; Coletta DK; Jenkinson C; Jhingan RM; Smokler D; Reyna S; Musi N; Khokka R; Federici M; Tripathy D; DeFronzo RA; Folli F
    Diabetologia; 2009 Oct; 52(10):2169-81. PubMed ID: 19633828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension.
    Basu R; Lee J; Morton JS; Takawale A; Fan D; Kandalam V; Wang X; Davidge ST; Kassiri Z
    Cardiovasc Res; 2013 Jun; 98(3):360-71. PubMed ID: 23524300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness.
    Cardellini M; Menghini R; Luzi A; Davato F; Cardolini I; D'Alfonso R; Gentileschi P; Rizza S; Marini MA; Porzio O; Lauro D; Sbraccia P; Lauro R; Federici M
    Diabetes; 2011 Dec; 60(12):3265-70. PubMed ID: 21984580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of tissue inhibitor of metalloproteinase 3 in macrophages reduces atherosclerosis in low-density lipoprotein receptor knockout mice.
    Casagrande V; Menghini R; Menini S; Marino A; Marchetti V; Cavalera M; Fabrizi M; Hribal ML; Pugliese G; Gentileschi P; Schillaci O; Porzio O; Lauro D; Sbraccia P; Lauro R; Federici M
    Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):74-81. PubMed ID: 22015660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus.
    Menghini R; Uccioli L; Vainieri E; Pecchioli C; Casagrande V; Stoehr R; Cardellini M; Porzio O; Rizza S; Federici M
    Acta Diabetol; 2013 Dec; 50(6):907-10. PubMed ID: 23636268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury.
    Wang Z; Famulski K; Lee J; Das SK; Wang X; Halloran P; Oudit GY; Kassiri Z
    Kidney Int; 2014 Jan; 85(1):82-93. PubMed ID: 23760282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-92a regulates the expression levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 3 via sirtuin 1 signaling in hydrogen peroxide-induced vascular smooth muscle cells.
    Liu P; Su J; Song X; Wang S
    Mol Med Rep; 2018 Jan; 17(1):1041-1048. PubMed ID: 29115493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirt1 activation prevents high glucose-induced angiotensin converting enzyme 2 downregulation in renal tubular cells by regulating the TIMP3/ADAM17 pathway.
    Guo Z; Niu Q; Mi X; Yang B; Cai M; Liang Y
    Mol Biol Rep; 2024 Jan; 51(1):81. PubMed ID: 38183511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMP‑3 suppresses the proliferation and migration of SMCs from the aortic neck of atherosclerotic AAA in rabbits, via decreased MMP‑2 and MMP‑9 activity, and reduced TNF‑α expression.
    Zhai H; Qi X; Li Z; Zhang W; Li C; Ji L; Xu K; Zhong H
    Mol Med Rep; 2018 Aug; 18(2):2061-2067. PubMed ID: 29956789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia.
    Cesaro A; Abakar-Mahamat A; Brest P; Lassalle S; Selva E; Filippi J; Hébuterne X; Hugot JP; Doglio A; Galland F; Naquet P; Vouret-Craviari V; Mograbi B; Hofman PM
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1332-43. PubMed ID: 19299578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy.
    Fogarasi M; Janssen A; Weber BH; Stöhr H
    Matrix Biol; 2008 Jun; 27(5):381-92. PubMed ID: 18295466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice.
    Menghini R; Menini S; Amoruso R; Fiorentino L; Casagrande V; Marzano V; Tornei F; Bertucci P; Iacobini C; Serino M; Porzio O; Hribal ML; Folli F; Khokha R; Urbani A; Lauro R; Pugliese G; Federici M
    Gastroenterology; 2009 Feb; 136(2):663-72.e4. PubMed ID: 19027012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM17 cleaves the insulin receptor ectodomain on endothelial cells and causes vascular insulin resistance.
    Ghiarone T; Castorena-Gonzalez JA; Foote CA; Ramirez-Perez FI; Ferreira-Santos L; Cabral-Amador FJ; de la Torre R; Ganga RR; Wheeler AA; Manrique-Acevedo C; Padilla J; Martinez-Lemus LA
    Am J Physiol Heart Circ Physiol; 2022 Oct; 323(4):H688-H701. PubMed ID: 36018759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha.
    Federici M; Hribal ML; Menghini R; Kanno H; Marchetti V; Porzio O; Sunnarborg SW; Rizza S; Serino M; Cunsolo V; Lauro D; Mauriello A; Smookler DS; Sbraccia P; Sesti G; Lee DC; Khokha R; Accili D; Lauro R
    J Clin Invest; 2005 Dec; 115(12):3494-505. PubMed ID: 16294222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TACE inhibition amplifies TNF-alpha-mediated colonic epithelial barrier disruption.
    Fréour T; Jarry A; Bach-Ngohou K; Dejoie T; Bou-Hanna C; Denis MG; Mosnier JF; Laboisse CL; Masson D
    Int J Mol Med; 2009 Jan; 23(1):41-8. PubMed ID: 19082505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM-9, ADAM-15, and ADAM-17 are upregulated in macrophages in advanced human atherosclerotic plaques in aorta and carotid and femoral arteries--Tampere vascular study.
    Oksala N; Levula M; Airla N; Pelto-Huikko M; Ortiz RM; Järvinen O; Salenius JP; Ozsait B; Komurcu-Bayrak E; Erginel-Unaltuna N; Huovila AP; Kytömäki L; Soini JT; Kähönen M; Karhunen PJ; Laaksonen R; Lehtimäki T
    Ann Med; 2009; 41(4):279-90. PubMed ID: 19253070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression.
    Kornfeld JW; Meder S; Wohlberg M; Friedrich RE; Rau T; Riethdorf L; Löning T; Pantel K; Riethdorf S
    Br J Cancer; 2011 Jan; 104(1):138-45. PubMed ID: 21102583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.